Metronidazol Generis

Metronidazole, the active ingredient in Metronidazol Generis, is a Nitroimidazole antibiotic presented as an oral tablet for oral use. It treats anaerobic bacterial infections and selected protozoal diseases in adults and children as prescribed. It is indicated for infections caused by susceptible anaerobic bacteria and certain protozoa, and is commonly used in both inpatient and outpatient settings.

GNH USA supplies Metronidazol Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Metronidazole is used to treat infections caused by anaerobic bacteria and certain protozoa.

Anaerobic bacterial infections: eradicates susceptible anaerobic organisms, reducing infection severity. Bacterial vaginosis: restores normal vaginal flora by eliminating pathogenic anaerobes. Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing transmission. Amoebiasis: kills Entamoeba histolytica trophozoites, treating intestinal and extra‑intestinal disease. Giardiasis: clears Giardia lamblia infection, relieving gastrointestinal symptoms. Clostridioides difficile infection (adjunctive therapy): used alongside standard therapy to reduce toxin production.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Metallic taste - Diarrhea - Headache

Serious or Rare Side Effects: - Seizures - Peripheral neuropathy - Severe allergic reactions

When prescribing Metronidazol Generis, clinicians should consider several precautionary measures to ensure safe use.

Renal function: assess baseline renal function and adjust dose in severe impairment. Hepatic function: monitor liver enzymes in patients with hepatic disease. Alcohol consumption: avoid alcohol to prevent disulfiram‑like reaction. Pregnancy: use only if potential benefit justifies risk, as safety data are limited. Hypersensitivity: discontinue if signs of allergic reaction appear. Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Metronidazole can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction. - Warfarin: enhanced anticoagulant effect, increasing bleeding risk. - Lithium: increased lithium toxicity. - Rifampin: induces metabolism, reducing metronidazole efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced effectiveness, consider backup method. - Phenytoin: altered plasma levels of both drugs. - Cimetidine: may increase metronidazole concentrations, monitor for toxicity.